Products
- - Products Image
- - Products
  - APIs
  - R&D PIPELINE
Services
Company
- - Company Image
- - Company
  - ABOUT US
  - NETWORK
  - CAREERS
News
Contact

Month: February 2021

C² PHARMA Completes Multiple Regulatory Filings, Expands Portfolio

Posted on 23. February 202116. May 2023 by admin

Posted in Press Release

Search for:

Recent Posts

C2 PHARMA EXPANDS OPHTHALMIC API PORTFOLIO WITH NAPHAZOLINE HYDROCHLORIDE LAUNCH
C2 PHARMA Receives CEP Approval For Tropicamide
C2 PHARMA’s Upcoming Launch of Oxybuprocaine Hydrochloride
C2 PHARMA x PharmaSource Ophthalmics Buyer Guide
C2 PHARMA Receives DMF Approval in China for Pilocarpine Nitrate

Archives

Categories

General
Information Brief
podcast
Press Release
Video

Meta

Log in
Entries feed
Comments feed
WordPress.org

APIs

R&D Pipeline
Services
About Us
Network
Careers
News

CONTACT

info@c2pharma.com

General Terms of Sales
Data Privacy